Minimally invasive debridement and suture surgery in conjunction with adalimumab: Improving efficacy and mitigating recurrence in hidradenitis suppurativa
- 9 July 2026
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 95 (5) , 1470-1472
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2023YFC2508106)
- Peking University Third Hospital (BYSYZD2023019)
This publication has 4 references indexed in Scilit:
- Combination secukinumab and surgical intervention for moderate-to-severe hidradenitis suppurativa: A retrospective cohort studyJAAD International, 2025
- The Effect of Platelet Fibrin Plasma (PFP) on Postoperative Refractory Wounds: Physiologically Concentrated Platelet Plasma in Wound RepairTissue Engineering and Regenerative Medicine, 2024
- Adalimumab in conjunction with surgery compared with adalimumab monotherapy for hidradenitis suppurativa: A Randomized Controlled Trial in a real-world settingJournal of the American Academy of Dermatology, 2023
- Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis SuppurativaJAMA Surgery, 2021